chr14-102922666-G-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_030943.4(AMN):c.-23G>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.388 in 1,592,304 control chromosomes in the GnomAD database, including 123,872 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.42 ( 14519 hom., cov: 32)
Exomes 𝑓: 0.38 ( 109353 hom. )
Consequence
AMN
NM_030943.4 5_prime_UTR
NM_030943.4 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.64
Genes affected
AMN (HGNC:14604): (amnion associated transmembrane protein) The protein encoded by this gene is a type I transmembrane protein. It is thought to modulate bone morphogenetic protein (BMP) receptor function by serving as an accessory or coreceptor, and thus facilitates or hinders BMP binding. It is known that the mouse AMN gene is expressed in the extraembryonic visceral endoderm layer during gastrulation, but it is found to be mutated in amnionless mouse. The encoded protein has sequence similarity to short gastrulation (Sog) and procollagen IIA proteins in Drosophila. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 14-102922666-G-C is Benign according to our data. Variant chr14-102922666-G-C is described in ClinVar as [Benign]. Clinvar id is 1262486.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.558 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.424 AC: 64384AN: 151722Hom.: 14493 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
64384
AN:
151722
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.343 AC: 74710AN: 217602 AF XY: 0.342 show subpopulations
GnomAD2 exomes
AF:
AC:
74710
AN:
217602
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.384 AC: 553364AN: 1440464Hom.: 109353 Cov.: 37 AF XY: 0.381 AC XY: 272199AN XY: 714976 show subpopulations
GnomAD4 exome
AF:
AC:
553364
AN:
1440464
Hom.:
Cov.:
37
AF XY:
AC XY:
272199
AN XY:
714976
Gnomad4 AFR exome
AF:
AC:
18942
AN:
33306
Gnomad4 AMR exome
AF:
AC:
13419
AN:
41998
Gnomad4 ASJ exome
AF:
AC:
9634
AN:
25682
Gnomad4 EAS exome
AF:
AC:
4355
AN:
39224
Gnomad4 SAS exome
AF:
AC:
24628
AN:
83304
Gnomad4 FIN exome
AF:
AC:
16891
AN:
47426
Gnomad4 NFE exome
AF:
AC:
440476
AN:
1104402
Gnomad4 Remaining exome
AF:
AC:
22907
AN:
59674
Heterozygous variant carriers
0
17483
34966
52448
69931
87414
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
13602
27204
40806
54408
68010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.425 AC: 64469AN: 151840Hom.: 14519 Cov.: 32 AF XY: 0.419 AC XY: 31068AN XY: 74216 show subpopulations
GnomAD4 genome
AF:
AC:
64469
AN:
151840
Hom.:
Cov.:
32
AF XY:
AC XY:
31068
AN XY:
74216
Gnomad4 AFR
AF:
AC:
0.564409
AN:
0.564409
Gnomad4 AMR
AF:
AC:
0.382156
AN:
0.382156
Gnomad4 ASJ
AF:
AC:
0.369013
AN:
0.369013
Gnomad4 EAS
AF:
AC:
0.106935
AN:
0.106935
Gnomad4 SAS
AF:
AC:
0.279601
AN:
0.279601
Gnomad4 FIN
AF:
AC:
0.34893
AN:
0.34893
Gnomad4 NFE
AF:
AC:
0.398774
AN:
0.398774
Gnomad4 OTH
AF:
AC:
0.397156
AN:
0.397156
Heterozygous variant carriers
0
1841
3681
5522
7362
9203
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
586
1172
1758
2344
2930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Jul 15, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Mutation Taster
=300/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at